Anthony B Evnin's Net Worth

-$958 Thousand

Estimate Recalculated Sep 12, 2024 05:14PM EST

Who is Anthony B Evnin?

Anthony B Evnin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMOS CORP, CANTEL MEDICAL CORP, SONIC INNOVATIONS INC, RENOVIS INC, Coley Pharmaceutical Group, Inc., CONSTELLATION PHARMACEUTICALS INC, AVEO PHARMACEUTICALS INC, SUNESIS PHARMACEUTICALS INC, INFINITY PHARMACEUTICALS, INC., Juno Therapeutics, Inc., ACCELERON PHARMA INC, ICAGEN INC, and MEMORY PHARMACEUTICALS CORP.

SEC CIK

Anthony B Evnin's CIK is 0001239241

Past Insider Trading and Trends

2017 was Anthony B Evnin's most active year for acquiring shares with 18 total transactions. Anthony B Evnin's most active month to acquire stocks was the month of May. 2023 was Anthony B Evnin's most active year for disposing of shares, totalling 12 transactions. Anthony B Evnin's most active month to dispose stocks was the month of December. 2005 saw Anthony B Evnin paying a total of $350,000.90 for 275,473 shares, this is the most they've acquired in one year. In 2021 Anthony B Evnin cashed out on 12,132 shares for a total of $977,717.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHARMOS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jul 1
Form 4/A
+3.99%
371.13K
$0.05
$20,040.97
9.67M
May 8
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Jul 1
Form 4
+3.99%
370.43K
$0.05
$20,003.33
9.66M
May 8
Form 4
+488.65%
7.72M
—
—
9.29M
Apr 21
Form 4/A
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 15
Form 4
+11.52%
148.6K
$0.36
$53,200.59
1.44M
Aug 5
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 17
Form 4
∞
1.28M
—
—
1.28M
Oct 25
Form 3
—
0
—
—
0
No matching records found

CANTEL MEDICAL CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.13K
$80.59
-$977,717.88
0
Jun 2
Form 4
+18.98%
1.94K
—
—
12.13K
Jul 31
Form 4
+10.21%
713
—
—
7.7K
Jul 31
Form 4
+11.35%
712
—
—
6.98K
Jul 31
Form 4
+8.85%
510
—
—
6.27K
Jul 31
Form 4
+76.64%
2.5K
$77.88
$194,690.75
5.76K
Mar 15
Form 4
+158.48%
2K
$76.26
$152,525.40
3.26K
Jan 18
Form 4
∞
1.26K
—
—
1.26K
Jan 5
Form 3
—
0
—
—
0
No matching records found

SONIC INNOVATIONS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+61.51%
20.42K
$3.59
$73,361.80
53.62K
May 6
Form 4
-100.00%
-326.00
$10.91
-$3,556.66
0
Mar 11
Form 4
+53.28%
11.54K
—
—
33.2K
Feb 17
Form 4
∞
21.66K
—
—
21.66K
Feb 2
No matching records found

RENOVIS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.31M
—
—
0
May 2
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 16
Form 4
∞
5.68K
—
—
5.68K
May 10
Form 4
—
0
—
—
0
Feb 9
Form 4
+40,492.15%
1.8M
—
—
1.8M
Feb 10
Form 3
—
0
—
—
0
No matching records found

Coley Pharmaceutical Group, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.52M
—
—
2.52M
Aug 15
Form 3
—
0
—
—
0
No matching records found